title: Coagulopathy and Anticoagulation During Thoracic Surgery.
abstract: Coagulopathy and bleeding in thoracic surgery may be compounded by the chronic use of anticoagulants and antiplatelet agents. Timely preoperative cessation and postoperative resumption of these antithrombotic drugs are critical in reducing the risks of perioperative major bleeding and thromboembolism. This article describes the various strategies for the optimal perioperative management of antithrombotics based on individual assessment of each patient and the most recent multisociety guidelines.
authors.affiliation: Division of Cardiothoracic Surgery, Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL 32082, USA. Electronic address: thomas.mathew@mayo.edu.
authors.forename: Mathew
authors.initials: M
authors.lastname: Thomas
authors.affiliation: Division of General Thoracic Surgery, Mayo Clinic, 200 First Street Southwest, Rochester, MN 55205, USA.
authors.forename: K Robert
authors.initials: KR
authors.lastname: Shen
mesh_terms: D000925:Anticoagulants / Q000009:adverse effects* / Q000627:therapeutic use; D016063:Blood Loss, Surgical / Q000517:prevention & control*; D006801:Humans; D019990:Perioperative Care / Q000379:methods; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D018570:Risk Assessment / Q000379:methods; D019616:Thoracic Surgical Procedures / Q000009:adverse effects* / Q000379:methods; D013923:Thromboembolism / Q000517:prevention & control
chemical_list: D000925:Anticoagulants; D010975:Platelet Aggregation Inhibitors
keywords: Bleeding; Perioperative anticoagulation; Perioperative antiplatelets; Perioperative antithrombotics; Thromboembolism